BioSpace News Archive

Teva Pharmaceutical Industries Ltd. reported results for the quarter ended March 31, 2018.

Paradigm Spine, LLC, announced that the North American Spine Society (NASS) has issued a coverage policy recommendation for Lumbar Interlaminar Device without Fusion and with Decompression.

In a new report, Blockchain: Opportunities and Challenges in Healthcare, Chilmark Research details the ways blockchain technologies will enable transformation in how the healthcare industry records, stores, and shares information.

The American Cleft Palate-Craniofacial Association (ACPA) returned to the state for its five-day Annual Meeting in Pittsburgh, April 10-14.

Le-Vel presented THRIVEpalooza from April 27-29 at a completely sold-out New Orleans Convention Center.

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media (“BioLife” or the “Company”), today announced that the Company’s first quarter 2018 financial results will be released after market close on Thursday, May 10, 2018, and that the Company will host a conference call and live webcast at 1:30 p.m. PT that afternoon

DermTech, Inc. announced it is partnering with the Melanoma Research Foundation in support of five Miles for Melanoma Run/Walks held throughout the US, kicking off this month during Melanoma Awareness Month.

Topix Pharmaceuticals, Inc. has announced the launch of Glycolix Glyco-Urea KP Therapy.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company has reached alignment with the U.S. Food and Drug Administration (FDA) on a pivotal study design for lumasiran, an investigational RNAi therapeutic for the treatment of primary hyperoxaluria type 1 (PH1).

RTI Surgical, Inc. reported operating results for the first quarter of 2018.